Prasco Laboratories, Shire sales and marketing update

Shire granted Prasco exclusive rights to market an authorized generic of 500, 750 and 1000 mg Fosrenol lanthanum carbonate chewable tablets in the U.S. The companies declined to disclose details. Fos...